Prediction of Chemotherapy Toxicity After Four Cycles of R‐ CHOP Treatment for Diffuse Large B‐Cell Lymphoma: Effective Imaging Biomarkers of Body Composition

Documenti analoghi

• Melanoma of the Choroid and Ciliary Body in Children: Remission of Metastatic Melanoma of the Choroid After Treatment With Chemotherapy and Immune Checkpoint Inhibition
  di: Pia Tüller, et al.
  Pubblicazione: (2025)
• Adverse Prognostic Significance of Activation‐Induced Cytidine Deaminase in Diffuse Large B‐Cell Lymphoma Patients Treated With R‐ CHOP
  di: Mardiah Suci Hardianti, et al.
  Pubblicazione: (2026)
• Visceral Fat and Body Fat as Risk Factors for Methotrexate Toxicity in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
  di: Alda Daniela García‐Guzmán, et al.
  Pubblicazione: (2025)
• Neutrophil Elastase as a Prognostic Biomarker and Driver of Tumor Progression in Diffuse Large B‐Cell Lymphoma
  di: Xinyu Zheng, et al.
  Pubblicazione: (2026)
• Real‐World Outcomes of Polatuzumab Vedotin Plus R‐ CHP Versus R‐ CHOP ‐Based Regimens in Japanese Patients With Untreated Diffuse Large B‐Cell Lymphoma
  di: Masaaki Hotta, et al.
  Pubblicazione: (2026)